Case Report

Calciphylaxis: A Rare Association with Alcoholic Cirrhosis. Are Deficiencies in Protein C and S the Cause?

Authors: Anil K. Goli, MD, Sujatha A. Goli, MD, Lata S. Shah, MD, Ryland P. Byrd, Jr, MD, Thomas M. Roy, MD

Abstract

Calciphylaxis is a rare condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification. It is characterized by acute calcium deposition in the medial layer of small and intermediate dermal vasculature that can lead to epidermal ischemia, ulceration, and necrosis. Calciphylaxis typically occurs in patients with end-stage renal disease who are undergoing dialysis and who have secondary hyperparathyroidism. Even in this population the incidence is less than 1%. The cause of calciphylaxis is unknown. However, it has been suggested that deficiencies of protein C and protein S may play a role in the pathophysiology of this disorder. Our patient is the fourth with cirrhosis to be reported to have developed calciphylaxis and adds further evidence that low levels of these anticoagulant factors may be an important etiologic factor for development of calciphylaxis. This report should alert the clinician that calciphylaxis occurs in patients with cirrhosis and should stimulate further research concerning the possible role of protein C and protein S deficiency in calciphylaxis.


Key Points


* Calciphylaxis is a rare disorder.


* People with calciphylaxis typically have end-stage renal disease.


* Calciphylaxis is, however, associated with other disease processes including alcoholic cirrhosis.


* Protein C and S deficiencies may be involved in the pathogenesis of calciphylaxis.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Gilson RT, Milum E. Calciphylaxis: case report and treatment review. Cutis 1999;63:149–153.
 
2. Adrogue HJ, Frazier MR, Zeluff B, Suki WN. Systemic calciphylaxis revisited. Am J Nephrol1981;1:177–183.
 
3. Kent RB, III, Lyerly RT. Systemic calciphylaxis. South Med J 1994;87:278–281.
 
4. Budisavijevic MN, Cheek D, Ploth DW. Calciphylaxis in chronic renal failure. J Am Soc Nephrol1996;7:978–982.
 
5. Selye H. Calciphylaxis. Chicago; University of Chicago Press, 1962.
 
6. Khafif RA, Delima C, Silverberg A, Frankel R. Calciphylaxis and systemic calcinosis: collective review. Arch Intern Med 1990;150:956–959.
 
7. Bryant JH, White WH. A case of calcification of arteries and obliterative endarteritis, associated with hydronephrosis, in a child aged six months. Guys Hosp Rep 1898;55:17–20.
 
8. Gipstein RM, Coburn JW, Adams DA, Lee DBN, PArsa KP, Sellers A, Suki W, Massry SG. Calciphylaxis in man: a syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure. Arch Intern Med 1976;136:1273–1280.
 
9. Lungo-Somolinos A, Sanchez JL, Mendez-Coll J, et al. Calcifying panniculitis associated with polcystic kidney disease and chronic renal failure. J Am Acad Dermatol 1990;22:743–747.
 
10. Richardson JA, Herron G, Reitz R, et al. Ischemic ulceration of skin and necrosis of muscle in azotemic hyperparathyroidism. Ann Intern Med 1969;71:129–133.
 
11. Fox R, Banowsky L, Cruz AB. Postrenal transplant calciphylaxis: successful treatment with parathyroidectomy. J Urol 1983;129:362–363.
 
12. Rees JKH. Calciphylaxis in man. Br Med J 1969;2:670–672.
 
13. Chavel SM, Taraszka KS, Schaffer JV, et al. Calciphylaxis associated with acute, reversible renal failure in the setting of alcoholic cirrhosis. J Am Acad Dermatol 2004;50:S125–128.
 
14. Fader J, Kang S. Calciphylaxis without renal failure. Arch Dermatol 1996;132:837–838.
 
15. Lim SP, Batta K, Tan BB. Calciphylaxis in a patient with alcoholic liver disease in the absence of renal failure. Clin Exp Dermatol 2003;28:34–36.
 
16. Manco-Johnson MJ, Knapp-Clevenger R. Activated protein C concentrates reverses purpura fulminans in severe genetic protein C deficiency. J Pediatr Hematol Oncol 2004;26:25–27.
 
17. Mahasandana C, Suvatte V, Chuansumrit A, et al. Homozygous protein S deficiency in an infant with purpura fulminans. J Pediatr 1990;117:750–753.
 
18. Chan YC, Valenti D, Mansfield AO, et al. Warfarin induced skin necrosis. Br J Surg 2000;87:266–272.
 
19. Mathur RV, Shortland JR, El Nahas AM. Calciphylaxis. Postgrad Med J 2001;77:557–561.
 
20. Dean SM, Werman H. Calciphylaxis: a favorable outcome with hyperbaric oxygen. Vasc Med1998;3:115–120.
 
21. Hafner J, Keusch G, Wahl C, et al. Uremic small-artery disease with medial calcification and intimal hyperplasia: a complication of chronic renal failure and benefit from parathyroidectomy. J Am Acad Dermatol 1995;33:954–962.
 
22. Cicone JS, Petronis JB, Embert CD, et al. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kid Dis 2004;43:110401108.
 
23. Chan YL, Mahony JF, Turner JJ, Poen S. The vascular lesions associated with skin necrosis in renal disease. Br J Dermatol 1983;10:985–995.